Extended Release Dosage Form

Known as: Extended Release Dose Form, ER, Extended Release 
A solid, semi-solid, solution or suspension designed to release active and/or inert ingredient(s) at a controlled, prolonged rate so as to reduce… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND Despite several antimuscarinic treatment options for overactive bladder (OAB), there is still a need for distinct… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND To evaluate the effectiveness of quetiapine extended release once daily in bipolar depression. METHODS Double-blind… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Tapentadol is a novel, centrally acting analgesic with mu-opioid receptor agonist and norepinephrine reuptake… (More)
  • figure 1
  • table I
  • figure 2
  • table II
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
OBJECTIVE To evaluate the efficacy and safety of tapentadol extended release (ER) for the management of moderate to severe… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Tapentadol is a novel, centrally acting analgesic with 2 mechanisms of action: µ-opioid receptor agonism and… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVE With this study we assessed the efficacy and safety of an extended-release formulation of guanfacine compared with… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To determine the efficacy, tolerability, and safety of fesoterodine in subjects with overactive bladder (OAB… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
CONTEXT Men with overactive bladder and other lower urinary tract symptoms may not respond to monotherapy with antimuscarinic… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVE To compare two new generation antimuscarinics at their recommended doses for treatment of overactive bladder syndrome… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
High molecular weight (Mw) chitosan (CS) solutions have already been proposed as vehicles for nasal immunization. The aim of the… (More)
Is this relevant?